iDNA Genomics Public (CYS:IDNA) OCF Margin %: 0.00% (As of . 20)


CYS:IDNA iDNA Genomics Public Ltd CYS:IDNA
23 GF Score
Price €22.80
! 2 Warning Signs
View Full Analysis

What is iDNA Genomics Public OCF Margin %?

iDNA Genomics Public CYS:IDNA 23 OCF Margin % is 0.00% as of . 20. GuruFocus rates CYS:IDNA with a GF Score™ of 23/100. The stock has 2 warning signs investors should review.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. iDNA Genomics Public's Cash Flow from Operations for the six months ended in . 20 was €0.00 Mil. iDNA Genomics Public's Revenue for the six months ended in . 20 was €0.00 Mil. Therefore, iDNA Genomics Public's OCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, iDNA Genomics Public's current OCF Yield % is 0.00%.

The historical rank and industry rank for iDNA Genomics Public's OCF Margin % or its related term are showing as below:


CYS:IDNA's OCF Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 4.67
* Ranked among companies with meaningful OCF Margin % only.

iDNA Genomics Public OCF Margin % Related Terms

iDNA Genomics Public OCF Margin % Historical Data

* Premium members only.

The historical data trend for iDNA Genomics Public's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iDNA Genomics Public OCF Margin % Chart

iDNA Genomics Public Annual Data
Trend
OCF Margin %

iDNA Genomics Public Semi-Annual Data
OCF Margin %
CYS:IDNA
23GF Score
iDNA Genomics Public Ltd CYS:IDNA
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iDNA Genomics Public OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

iDNA Genomics Public's OCF Margin for the fiscal year that ended in . 20 is calculated as

OCF Margin=Cash Flow from Operations (A: . 20 )/Revenue (A: . 20 )
=/
= %

iDNA Genomics Public's OCF Margin for the quarter that ended in . 20 is calculated as

OCF Margin=Cash Flow from Operations (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
iDNA Genomics Public (CYS:IDNA) has a OCF Margin % of 0.00% as of . 20. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on iDNA Genomics Public and its competitors.
Is iDNA Genomics Public's OCF Margin % too high?
iDNA Genomics Public's current OCF Margin % is 0.00%. Overall, iDNA Genomics Public has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does iDNA Genomics Public's OCF Margin % compare to ?
iDNA Genomics Public's OCF Margin % of 0.00% can be compared against companies in the Medical Diagnostics & Research industry. The industry median OCF Margin % is 4.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.67, based on 203 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on iDNA Genomics Public and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iDNA Genomics Public's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iDNA Genomics Public stock overvalued right now?
iDNA Genomics Public (CYS:IDNA) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. iDNA Genomics Public's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For iDNA Genomics Public (CYS:IDNA), the current OCF Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

iDNA Genomics Public Business Description

Comparable Companies
Address 7 Hatzidaki Street, Trypiotis, Nicosia, CYP, 1066
iDNA Genomics Public Ltd operates in the field of genomics and biotechnology and specializes in personalized health care. Its purpose is to develop and provide genetic tests in the field of genomics, through professionals (Medical Genomics) and directly to the consumer (Direct-to-Consumer Genomics).
23GF Score

Get the complete analysis for CYS:IDNA

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.80
Price